Ethical Decision Making in First Trimester Pregnancy Screening

  title={Ethical Decision Making in First Trimester Pregnancy Screening},
  author={Lisa Zindler},
  journal={The Journal of Perinatal \& Neonatal Nursing},
  • Lisa Zindler
  • Published 1 April 2005
  • Medicine
  • The Journal of Perinatal & Neonatal Nursing
Many couples enter pregnancy without an intricate understanding of the potential maternal and fetal/newborn complications. While it is reasonable for expectant couples to consider only the positive outcomes, it is the role of the healthcare professional to educate the parents on the options for fetal screening and testing. Once couples have this information, it is their opportunity to consider the options according to their beliefs and values. In reviewing the principles of ethics, healthcare… 

Topics from this paper

Perinatal Ethics: State of the Science
  • L. Callister
  • Medicine
    The Journal of perinatal & neonatal nursing
  • 2006
Ethical issues in the delivery of healthcare across the childbearing year are presented, including preconception issues and conception issues, and dilemmas that occur during pregnancy, during labor and birth, and in the early postpartum period.
Informing on prenatal screening for Down syndrome prior to conception. An empirical and ethical perspective
It is proposed to incorporate an information offer on prenatal screening for Down syndrome in preconception care consultations by offering information, instead of providing information, prospective parents are enabled to either accept or decline the information, which respects both their right to know and their right not toknow.
Prenatal Screening and Counseling in Iran and Ethical Dilemmas
Iranian scholars were willing to consider prenatal screening to help prevent transmission of diseases to the next generation through the autonomous choice of the couple to participate in prenatal screening and counseling.
Risk assessment and risk distortion: finding the balance.
Pregnancy and birth have been conceptualized as medically problematic, with all pregnant women considered at risk and in need of medical monitoring, and the use of technology in caring for pregnant women becomes normalized.
Ethical Considerations in Live Liver Donation to Children
moral questions in human life while providing structure to determine which rules apply to a situation.1 Every day, health care providers must use ethical principles to determine right from wrong, to
Decision making following a prenatal diagnosis of Down syndrome: an integrative review.
Multiple factors influence women's decision making following a diagnosis of DS, including demographic factors such as religion, maternal age, gestational age, number of existing children, and history of induced abortion.
Advances in fetal genetic diagnosis and therapy: ethical issues and appropriate technology in cost-restrained countries.
  • M. Titus, J. Moodley
  • Medicine
    Best practice & research. Clinical obstetrics & gynaecology
  • 2012
This chapter addresses ethical issues in prenatal diagnosis and fetal therapy and concludes that, if an abnormality can be corrected prenatally, prognosis can be improved significantly, as the initial problem does not necessarily threaten the fetus.
Ethical considerations in live liver donation to children.
  • K. Ventura
  • Medicine
    Progress in transplantation
  • 2010
An ethical review of issues that arise during live liver donation from a parent to a child is provided.
Effect of Shared Decision-making on Decisional Conflict and Uptake of First-trimester Screening Tests
Introduction: Several factors influence women’s decision to take First Trimester Screening (FTS) tests. These factors are associated with the ambivalence of women toward undergoing screening tests.
Prenatal screening for Down syndrome and for structural congenital anomalies in the Netherlands: Information provision, informed decision-making and participation
The goal of the active, routine offer of information about prenatal screening for Down syndrome and structural congenital anomalies, is to enable prospective parents to make an autonomous informed decision about whether or not to participate in the prenatal screening program.


Should all pregnant women have an ultrasound examination?
  • F. Chervenak, L. McCullough
  • Medicine
    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • 1994
The methods of ethical analysis and argument are used to show that the principle of respect for autonomy creates an obligation to inform every pregnant woman about the availability of obstetric ultrasound in settings in which quality ultrasound is available.
Ethics in fetal medicine.
The concept of the fetus as a patient is introduced and its implications for directive versus non-directive counselling and two current clinical controversies, routine obstetric ultrasound and termination of third trimester pregnancy are taken up.
First‐Trimester Sonographic Screening for Down Syndrome
An objective assessment of the literature describing nuchal translucency, as well as some adjunct first-trimester sonographic techniques, such as ductus venosus flow and nasal bone studies are provided.
First-trimester screening for trisomies 21 and 18.
First-trimester screening for trisomies 21 and 18 on the basis of maternal age, maternal levels of free beta human chorionic gonadotropin and pregnancy-associated plasma protein A, and measurement of fetal nuchal translucency has good sensitivity at an acceptable false positive rate.
Sequential Pathways of Testing After First-Trimester Screening for Trisomy 21
The data demonstrate that a sequential screening program that provides patients with first-trimester results and offers the option for early invasive testing or additional serum screening in the second trimester can detect 98% of trisomy 21–affected pregnancies.
First trimester screening for aneuploidy: serum biochemical markers.
The article reviews screening for Down syndrome in the first trimester (8-13 gestational weeks) with maternal serum analytes, finding that pregnancy-associated plasma protein-A and free beta-hCG in combination with maternal age is not as good as the screening performance of second trimester triple or quad markers.
First-trimester screening for aneuploidy: research or standard of care?
Until the results of two major trials are available, the current standard of care with respect to Down syndrome screening should not be changed, and first-trimester screening should remain investigational.
Informed consent for maternal serum alpha-fetoprotein screening in an inner city population: how informed is it?
OBJECTIVE To determine if women who received information from a provider and viewed a videotape about maternal serum alpha-fetoprotein (MSAFP) screening understood enough to sign informed consent.
The median maternal serum alpha-fetoprotein (AFP) level at 14-20 weeks' gestation in 61 pregnancies associated with Down syndrome was 0.72 multiples of the median (MoM) value for a series of 36 652
First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
First-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A screening for Down syndrome can achieve detection rates as high as those associated with alpha-fetoprotein and human chorionics gonadotropicin or alpha- Fetoprotein, human chorsedotropin, and unconjugated estriol screening in the second trimester.